RainDance Technologies opens patent suit against 10X Genomics

RainDance Technologies has opened a patent infringement case against 10X Genomics. The suit alleges that 10X Genomics--which exited stealth mode and raised $55.5 million last month--is using tech protected by patents licensed to RainDance from the University of Chicago. 10X Genomics has hit back against the claims. "We are firmly of the view that our products do not infringe any claims of any of the asserted patents," CEO Serge Saxonov said in a statement. Release | More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.